Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 701–800 of 1,002
Recent advances in nanotechnology for combating Alzheimer's disease
Hu, C., Wu, B., Wu, Y., Shi, M., Ma, J., Gao, H., & Zhang, J. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00493g · Cited by 8
Gardner, R. S., Kyle, M. M., Hughes, K., & Zhao, L. (2024) · Biomolecules · doi:10.3390/biom14070827 · Cited by 8
“Although numerous reports demonstrate that A β clearance is enhanced by pro-inflammatory signaling or cytokines [23,47–50], persistent or chronic inflammation is generally thought to enhance A β spreading and aggregation [51], creating a vicious cycle leading to neurodegeneration [52].”
BackgroundNon-Communicable Neurological Disorders and Neuroinflammation
Ballerini, C., NJAMNSHI, A. K., Juliano, S. L., Kalaria, R. N., Furlan, R., & Akinyemi, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834424 · Cited by 10
Huang, J., Chen, D., Lin, X., Yang, C., & Lin, X. (2022) · Hippocampus · doi:10.1002/hipo.23491 · Cited by 7
“The MWM test includes two phases: 4-day navigation training and 1-day spatial probe test (Asai et al., 2015; Tang & Le, 2016; Venegas et al., 2017).”
MethodEmerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 8
Ramesha, S., Rayaprolu, S., & Rangaraju, S. (2020) · Journal of Visualized Experiments · doi:10.3791/61467 · Cited by 9
Research progress on microglial pyroptosis and inflammasomes: a comprehensive analysis
Wang, X., Li, Z., Ma, B., & Jia, Q. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1582579 · Cited by 10
Zhu, Q., Song, Y., Qian, Y., Zhang, R., Xue, J., & Hou, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.25 · Cited by 10
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 7
“101,143,144 151”
Nanozymes - A new opportunity for the treatment of neurodegenerative diseases
Zhou, Y., Zhou, X., Song, Y., Tian, Q., Li, S., Li, T., & Lu, X. F. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169965 · Cited by 7
The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis
Wang, T., Feng, L., & Tian, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102980 · Cited by 6
Zhao, P., Li, S., Liu, Q., Peng, X.-C., Liu, L., Yang, F.-Y., Wang, C., Qian, F., & Tang, F.-R. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1726194 · Cited by 7
“Moreover, A β itself can activate microglia and be phagocytosed, alleviating its accumulation in the brain (Condello et al., 2015); however, A β can also trigger apoptosis-associated speck-like protein (ASC) aggregation, promoting plaque formation (Venegas et al., 2017).”
Vaccari, J. P. D. R., Davis, D. A., Sawaya, A. P., Garamszegi, S. P., Sun, X., Barreda, A., Bramlett, H. M., Gultekin, S. H., Dietrich, W. D., Keane, R. W., et al. (2026) · Brain Pathology · doi:10.1111/bpa.70086 · Cited by 7
“63 It is possible that in response to DAMPs released in the NP, AIM2 forms an inflammasome with ASC, supporting our earlier findings (10).”
Neuroinflammation and Neuroimmunomodulation in Alzheimer’s Disease
Hong, Y., Xu, J. L., Hu, Y., Li, L., Dong, Z., Zhu, T.-K., & Wei, Y.-Q. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0148-z · Cited by 7
Gao, Y., Li, S., Zhang, Y., Zhang, J., Zhao, Y., Cui, C., Gao, X., & Yang, G. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00585-5 · Cited by 6
Ansai, O., Miyauchi, T., Hayashi, R., Katsumi, T., Nishiguchi, T., Hasegawa, A., Shinkuma, S., Natsuga, K., Nomura, T., Shimomura, Y., et al. (2022) · Clinical and Experimental Dermatology · doi:10.1093/ced/llac069 · Cited by 7
Tooth loss impairs cognitive function in SAMP8 mice via the NLRP3 /Caspase‐1 pathway
Sun, X., Lu, Y., Pang, Q., Luo, B., & Jiang, Q. (2023) · Oral Diseases · doi:10.1111/odi.14646 · Cited by 7
Wang, X., Wang, Q., Wang, X., Zhao, H., Zhao, C., Jiao, Y., Shi, H., Chen, C., Chen, H., Wang, P., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115002 · Cited by 6
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 7
Chen, I., Chen, W.-L., Chang, K., Lee, J.-W., Lin, T., Lin, W., Chen, C., & Lee‐Chen, G. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176370 · Cited by 6
Gulácsy, C. E., Meade, R. M., Catici, D. A. M., Soeller, C., Pantoş, G. D., Jones, D. D., Alibhai, D., Jepson, M. A., Valev, V. K., Mason, J. M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00322 · Cited by 6
Microbial and immune factors regulate brain maintenance and aging
Travier, L., Singh, R., Fernández, D. S., & Deczkowska, A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102607 · Cited by 7
ASC nanobodies to counteract the consequences of inflammasome activation
Adriouch, S., & Pelegrín, P. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216087 · Cited by 6
“…diseases, such as chronic obstructive pulmonary disease, cryopyrin-associated periodic syndromes, sepsis, Alzheimer’s disease, nonalcoholic fatty liver disease and liver fibrosis (Baroja-Mazo et al, 2014; Franklin et al, 2014; Venegas et al, 2017; Mart ınez-Garc ıa et al, 2019; Gaul et al, 2020).”
BackgroundPlexin B2 in physiology and pathophysiology of the central nervous system
Wang, Q., Zhang, Y., Ma, K., Lin, P., Wang, Y., Wang, R., Li, H., Li, Z., & Wang, G. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114627 · Cited by 6
Microglial colonization routes and their impacts on cellular diversity
Hattori, Y. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.04.004 · Cited by 6
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD
Woo, M. S., Therriault, J., Hosseini, S. A., Wang, Y.-T., Macedo, A. C., Rahmouni, N., Aumont, É., Servaes, S., Tissot, C., Arias, J. F., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00316-1 · Cited by 7
“Furthermore, in fl ammatory cell death of microglia, pyroptosis, strongly promotes A β -accumulation, providing mechanistic evidence for an involvement of in fl ammation in the earliest AD stages (Venegas et al, 2017; Heneka, 2017).”
InfluentialAkinluyi, E. T., Takahashi, K., Connolly, M. G., Poon, W. W., & Macauley, M. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00805 · Cited by 5
Liu, R., Deng, Q., Gong, L., & Yang, L. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01598-2 · Cited by 6
“This inhibition not only reduces the phosphorylation of tau at pathogenic epitopes but also suppresses NF-κB-mediated neuroinflammation, promoting a shift toward the neuroprotective M2 phenotype [216, 332, 333].”
InfluentialChen, B., Lu, H.-C., Huang, L., Wang, J., Bujold, M., Tang, L., Du, X., & Wang, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03733-2 · Cited by 6
HDAC6 regulates BACE1 stability and NLRP3 inflammasome activation in Alzheimer's disease
Lee, J., Cho, Y., Choi, B. Y., Kim, H. K., Lee, Y., Kim, E., Han, J., Sul, J. H., Kim, J. S., Baek, S. H., et al. (2026) · Brain · doi:10.1093/brain/awag089 · Cited by 5
The Central Role of Neuronal Cell Death in Alzheimer’s Disease Pathobiology
Kwak, S., Kim, J. K., Lee, Y., Baek, H. S., Kwon, Y. J., Park, M.-N., Hong, J., Lee, S.-B., Kim, H. W., & Kim, S. H. (2026) · Biomedicines · doi:10.3390/biomedicines14050953 · Cited by 6
“Microglia respond robustly to fibrillar and oligomeric A β by activating the NLRP3 inflammasome, leading to caspase-1 activation, interleukin-1 β release, and establishment of a self-amplifying inflammatory loop [9,72].”
InfluentialNeuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24
Magadi, S. S., Jonson, M., Lucena, P. B., Caliandro, M. F., Almeida, B., Bilalli, L., Budinger, D., Tsoi, A., Ntzouni, M. P., Maqdissi, J. A., et al. (2026) · Brain · doi:10.1093/brain/awag166 · Cited by 5
Self-citationPeriodontal disease and brain amyloid pathology in mild cognitive impairment
Gil-Montoya, J. A., Gerez-Muñoz, M. J., Triviño‐Ibáñez, E. M., Carrera-Muñoz, I., Bravo, M., Rashki, M., Solis‐Urra, P., Esteban‐Cornejo, I., & Gómez-Río, M. (2024) · Neurología · doi:10.1016/j.nrl.2023.03.004 · Cited by 6
Xie, J., Tandon, R., & Mitchell, C. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031062 · Cited by 5
Thiolutin, a novel NLRP3 inflammasome inhibitor, mitigates IgA nephropathy in mice
Zhang, Y., Shi, S., Lin, C., Zeng, Q., Che, L., Li, Y., & Lin, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114440 · Cited by 6
Sotoudeh, H., Alizadeh, M., Shahidi, R., Shobeiri, P., love, N., & Singhal, A. (2022) · Radiology Case Reports · doi:10.1016/j.radcr.2022.10.023 · Cited by 5
“Neuroinflammation [6] , vascular alterations [7 ,8] , aging [9] , and glymphatic dysfunction [10] work upstream”
BackgroundA Turning Point in Alzheimer’s Disease: Microbes Matter
Itzhaki, R. F. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-191171 · Cited by 5
Wood, J. I., Dulewicz, M., Ge, J., Stringer, K. M., Szadziewska, A., Desai, S., Koutarapu, S., Hajar, H. B., Blennow, K., Zetterberg, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.08.617019 · Cited by 5
Single-nucleus RNA sequencing of human periventricular white matter in vascular dementiaPreprint
Díaz-Pérez, S., DeLong, J. H., Rivier, C. A., Lee, C., Askenase, M. H., Zhu, B., Zhang, L., Brennand, K., Martins, A. J., & Sansing, L. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.06.627202 · Cited by 6
Wu, Z., Zhao, Y., Hao, S., An, M., Song, C., & Li, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01371 · Cited by 5
“Venegas et al. (2017) reported that neuroinflammation can accelerate Aβ aggregation and increase microglial toxicity under AD-associated pathological conditions.”
Alvarez, E. C., Sfogliarini, C., Rosa, F. L., Saresella, M., Dolci, M., Vegeto, E., Taramelli, D., Basilico, N., & Clerici, M. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03574-5 · Cited by 4
“Notably, ASC specks released by activated microglia can bind to Aβ, enhancing its cerebral aggregation and deposition as well as the spreading of Aβ brain pathology [81].”
Liu, T., Chen, D., Liu, F., & Sun, Y. T. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10139-6 · Cited by 5
“In contrast to previous strategies primarily focused on directly inhibiting down-stream effector molecules (Venegas et al. 2017), ZFP36 functions as an upstream regulator, exerting a hub role through broader post-transcriptional regulation (Ferri et al. 2025; Qin et al. 2025).”
Filament-mediated repurposing of toxic dITP for immunity in the Kongming system
Feng, H., Shao, K., Zeng, Z., Tan, E. Y. J., Hu, Z., Zhao, R., Rao, J., Shi, J., Chen, Z., Pinilla‐Redondo, R., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.01.027 · Cited by 4
Zhang, S., Gu, X. F., Zhang, M., Ding, N., Yang, J., & Wang, T. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418553 · Cited by 4
“52,53 Meanwhile, these aforementioned mediators and abnormal proteins such as aggregated A β or hyperpho-sphorylated tau activate microglia to propagate downstream pathways, including MAPK, NF-κ B, and PI3K/Akt.”
Zhang, Y., Zhao, B., Li, L., Li, C. J., Gao, Y., Hong, Y., & Gu, Z. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17073 · Cited by 5
Li, H., Terrando, N., & Gelbard, H. A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_24 · Cited by 4
Dexamethasone does not ameliorate gliosis in a mouse model of neurodegenerative disease
Ye, X., Zou, G., Hou, J., Bi, H., Zhou, C., Wang, R., Xu, Y., Wang, C., Chen, G., Yin, Z., et al. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100817 · Cited by 4
Alzheimer Disease: A Life-Limiting Disease With a Burden of a Terminal Illness
Waziry, R., & Williams, O. A. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200208 · Cited by 4
Luan, X., Li, G., Ding, Y., Sun, J., Li, X., Jiang, W., Shi, Y., He, M., Guo, J., Fan, R., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117734 · Cited by 4
Huang, Z., Gong, Z., Lin, Y., Yang, F., Chen, W., Xiang, S., Huang, Y., Xiao, H., Xu, S., & Duan, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1267780 · Cited by 5
“…apoptosis-associated speck-like protein containing a CARD (ASC), after the NACHT-,LRR-and pyrin (PYD)-domain-containing protein 3 (NLRP3) inflammasome activation induced by A β , causing them to bind rapidly to A β and promote the production of A β oligomers and aggregates (Venegas et al., 2017).”
BackgroundEagle, S. R., Sherry, N. S., Kershaw, E. E., Basantani, M. K., Puccio, A. M., McIntyre, P., Henry, R. J., & Okonkwo, D. O. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123159 · Cited by 4
Zhang, Z., Du, S., Chen, X., Qiu, D., Li, S., Han, L., Bai, H., & Gao, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312662 · Cited by 5
“Pyroptosis plays a significant role in neurodegeneration and neuroinflammation, which can cause a variety of CNS diseases, including sepsis [11], traumatic brain injury (TBI) [12], Alzheimer’s disease (AD) [13], and epilepsy [14].”
Alarcón‐Vila, C., Hurtado‐Navarro, L., Mateo, S. V., Peñín‐Franch, A., Martínez, C. M., Molina‐López, C., Baños, M. C., Gómez, A. I., Gómez‐Román, J., Baroja‐Mazo, A., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00176-1 · Cited by 4
Xu, Y., Scipioni, M., Blevins, H., & Zhang, S. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02692-4 · Cited by 4
Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42
Zhang, S., Guaglianone, G., Morris, M. A., Yoo, S., Howitz, W. J., Xing, L., Zheng, J., Jusuf, H., Huizar, G., Lin, J., et al. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00105 · Cited by 4
Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits
Li, W., Gan, L., Ma, F.-F., Feng, R., Wang, J., Li, Y., Sun, Y., Wang, Y.-J., Diao, X., Qian, F.-Y., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200619 · Cited by 6
“A (cid:2) deposits in APP-PS1 mice and patients can be immunoprobed using 6E10 antibodies [42, 43].”
The effect of Aβ seeding is dependent on the presence of knock-in genes in the AppNL−G−F mice
Lacoursiere, S. G., Safar, J., Westaway, D. A., Mohajerani, M. H., & Sutherland, R. J. (2022) · Frontiers in Dementia · doi:10.3389/frdem.2022.941879 · Cited by 5
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
“domain (ASC), can form speck-like aggregates by itself and contribute to pathological deterioration,(37) and act as a cross-seed for Aβ.(38) Additionally, NF-κB is activated and involved in the expression of cyto-”
BackgroundZhang, M., Cheng Ann, C. H. E. N., Peng, Q., Wu, X., Zhou, R., Ma, Y., & Zou, Z. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.017 · Cited by 4
Crosstalk between NLRP3 inflammasome and calpain in Alzheimer's disease
Mamsa, R., Prabhavalkar, K. S., & Bhatt, L. K. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16139 · Cited by 4
Picroside II Alleviates the Progression of Alzheimer’s Disease via the NLRP3/Caspase-1/GSDMD Pathway
Li, S., Gao, Y., Zhang, Y., Zhang, J., Zhao, Y., Chang, C., Gao, X., Zhang, J., & Yang, G. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08889-3 · Cited by 5
“The activation of hippocampal NLRP3 inflammasome-mediated pyroptosis is associated with neuronal damage, cognitive decline, and neuronal death (Hanslik & Ulland, 2020; Heneka et al., 2013; Ising et al., 2019; Venegas et al., 2017).”
Burton, E. A., Argenziano, M., Cook, K., Ridler, M., Lu, S., Su, C., Manduchi, E., Littleton, S. H., Leonard, M. E., Hodge, K. M., et al. (2024) · doi:10.1101/2024.08.22.609230 · Cited by 3
Nan, J., Ji, S., Zhou, N., Jiao, Y., Zhang, Y., Yang, S., Xiang, M., & Li, L. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117796 · Cited by 4
NLRP3 inflammasome: A link between systemic infection and Alzheimer’s disease
Barichello, T., & Dal‐Pizzol, F. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00073 · Cited by 5
Lian, W., Yuan, X., Zhou, F., Tong, Z., Cheng, Y., Zhang, W., He, J., & Xu, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120615 · Cited by 7
Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease
Tang, C., Han, K., Wen, X., Zhang, J., 孙维绎, Yue, X., Shi, L., Liu, Z., Zhao, J., Yan, C., et al. (2026) · Advanced Materials · doi:10.1002/adma.202520002 · Cited by 4
“ThT binding assays were performed according to previously described protocols [39].”
PLGA Nanoparticle-based Anti-TLR2 scFv Gene Delivery for the Treatment of Alzheimer’s Disease
Lee, S., Lee, J., Jeon, J., Lee, H., Choi, B., Hong, J., & Lee, S. J. (2026) · Experimental Neurobiology · doi:10.5607/en25047 · Cited by 4
“Many previous studies support a causal role for microglia activation and neuroinflammation in AD: microglial activation fosters Aβ aggregation, IL-1β drives tau phosphorylation, and elevated baseline indices of microglial activation predict tau propagation and cognitive deterioration [25-27].”
Cangalaya, C., Düsedau, H. P., Dunay, I. R., Dityatev, A. E., & Stoyanov, S. (2026) · Cells · doi:10.3390/cells15020182 · Cited by 3
“For example, microglia-derived ASC specks, a multiprotein complex within microglia, cross-seed A β in Alzheimer’s disease [11], supporting the established link between inflammasome activation and the initiation and spreading of A β pathology.”
InfluentialCui, J., Huang, R., & Dong, X. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178706 · Cited by 3
NLRP3 Inflammasome Activation in Oxidative Stress: A Key Mechanism Driving Neuroinflammation
Ramirez-Celis, C., Martínez-Torres, A. M., & Morán, J. (2026) · NeuroImmunoModulation · doi:10.1159/000551943 · Cited by 3
Yuan, Q., Liu, X., Zhang, Y., Xian, Y., Zou, J., Zhang, X., Huang, P., Song, Y., & Lin, Z. (2021) · Molecules · doi:10.3390/molecules26092685 · Cited by 3
Ramos, J. M. P., Kviatcovsky, D., & Schwartz, M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15609 · Cited by 3
“(2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.”
BackgroundInfluentialCoskuner‐Weber, O., Habiboglu, M. G., Teplow, D. B., & Uversky, V. N. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1546-1_8 · Cited by 3
An Assay for the Seeding of Homotypic Pyrin Domain Filament Transitions
Hochheiser, I. V., & Geyer, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2449-4_13 · Cited by 3
Self-citationMicrobubbles-based drug delivery for antiAlzheimer's drugs
Patel, M. B., Prajapati, B. G., & Yadav, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00006-6 · Cited by 3
Small Molecule Decoy of Amyloid-β Aggregation Blocks Activation of Microglia-Like Cells
Oasa, S., Chen, G., Schultzberg, M., & Terenius, L. Y. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231399 · Cited by 3
Lu, D., Yu, M., Chen, L., Ye, J., Huang, L., Zhu, G., & Lan, B. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1066 · Cited by 3
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.04.547548 · Cited by 3
Glia in Neurodegenerative Disease
Crowley, G., Attwell, D., Phatnani, H. P., Sontheimer, H. W., & Hong, S. Y. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041375 · Cited by 3
Qiu, T., Liu, Z.-Q., Gallego-Rudolf, J., Edde, M., Caron, A. V., Zhang, Y., Chakravarty, M. M., Soucy, J., Collins, D. L., Poirier, J., et al. (2025) · medRxiv · doi:10.1101/2025.09.25.25336640 · Cited by 3
RTN3 – ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy
Cheng, Q., & Zhang, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136333 · Cited by 3
CRM1 mediates ASC nuclear export and inflammasome activation
Cao, R., Lin, B., He, H., Wang, D., Wang, X., Huang, Y., & Zhou, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114503 · Cited by 2
Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications
Beschörner, N., Xu, Y., Jucker, M., & Ruiz‐Riquelme, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70267 · Cited by 3
“Moreover, ASC specks, which are structures released by microglia after inflammasome activation, bind to Aβ, increasing aggregation and deposition (Friker et al. 2020; Venegas et al. 2017).”
Enhancing Tyro3 signaling ameliorates IL-1β production through STAT1 in Alzheimer's disease models
Ravichandran, K. A., Brosseron, F., McManus, R. M., Ising, C., Görgen, S., Schmidt, S. V., Santarelli, F., Lee, S. Y., Jung, H., Chung, W., et al. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf157 · Cited by 2
Self-citationFrom knowledge landscapes to network mechanisms: charting regulated cell death pathways in ALS
Zhang, J., Zhao, Z., Xiang, T., Teng, D., Wan, H., Zhang, Q., & Liu, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1742805 · Cited by 2
“Beyond cytokines, ASC “specks” released from microglia can cross-seed A β , providing a plausible route for feed-forward propagation of proteinopathy alongside inflammatory damage (Venegas et al., 2017).”
Yuan, Q., Zhang, R., Hu, J., Lin, S., Zhu, Y., Geng, J., Du, G., Yang, X., Zhao, Y., Wang, D., et al. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103409 · Cited by 2
The aggregation of amyloid-β: from condensation, nucleation, and conformation to targeting therapy
Chen, B., Chen, T., Sun, Z., Liu, L., Jia, Y., Ji, Y., Wang, J., Sun, F., & Huang, Y. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124397 · Cited by 3
ÇELİK, H., Dalkılınç, E., Aydın, Ş., Çelik, O., Küçükler, S., Topal, A., Akay, R., Gönüllü, S., Yıldız, M. O., Alım, B., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05889-7 · Cited by 2
“In the literature, it has been demonstrated that the neuroinflammatory response initiated by microglial activation in the pathogenesis of AD accelerates neuronal damage through increased proinflammatory cytokines and suppression of anti-inflammatory mechanisms [65, 66].”
Bang-feng, L., Chen, X., Xie, R., Mo, Y.-F., Wu, Y.-Z., Meng, Y., Han, X.-L., Chen, M., & Peng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1818802 · Cited by 5
Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer’s disease
Chaudhary, B. N., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02274-7 · Cited by 2
“These processes ultimately result in progressive cognitive decline, synaptic dysfunction, and neuronal damage (Venegas et al. 2017 ).”
Liu, Y., Ye, Y., Fan, M., Cheng, Y., Sun, S., & Qiu, Z. (2026) · Neuron · doi:10.1016/j.neuron.2026.05.015 · Cited by 3
Mikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 3
“A striking discovery is that activation of NLRP3 in AD not only produces inflammatory cytokines but also leads to the release of Apoptosis-associated https://doi.org/10.3390/cells15121111 Speck-like protein containing a CARD (ASC) specks (the inflammasome adaptor protein aggregates) [40].”
InfluentialZhang, H., Tu, R., Zhang, D., Xiangyue, M., Yu, M., Ding, S., Ma, C., Qiu, X., Yu, X., & Yin, H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1890903 · Cited by 2
“This effect was reduced when an anti-ASC antibody was used (Venegas et al., 2017).”
Combating ageing beyond the cell: Emerging roles of extracellular proteostasis
Venkatesh, S. R., Gallotta, I., Olabiyi, B. F., Choi, Y. H., Inglesfield, S., Kumita, J. R., Ewald, C. Y., & David, D. C. (2026) · FEBS Journal · doi:10.1111/febs.70647 · Cited by 2
“Immune cells fuel extracellular protein aggregation through the release of hypochlorous acid (HOCl) [213] and apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), which cross-seeds A b and serum amyloid A fibril formation [214,215].”
Delaney, H. J., Islam, S., Healy, D., Oglesby, R., Konda, M., Rietman, G. M., Lynch, R., Nazmi, A., Murray, J. T., Cunningham, M. O., et al. (2026) · Brain · doi:10.1093/brain/awag147 · Cited by 2
廉文文, Zhou, F., Tong, Z., 夏聪媛, Yu, Y., He, J., Jiekun, X., & Zhang, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103273 · Cited by 2
Li, S., Jin, J., Liu, Y., Yuan, J., Dong, Y., Wang, Z., Lu, L., & Zhang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261469862 · Cited by 2
“55,59 Importantly, NLRP3-driven cytokine release and pyroptosis can further aggravate mitochondrial stress and redox imbalance, closing a feed-forward loop between metabolic injury and in fl ammatory escalation.”
New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Key Factors Regulating the Interdomain Dynamics May Contribute to the Assembly of ASC
Li, T., Pineda, L. I. G., Stevens, A. O., & He, Y. J. (2023) · Biology · doi:10.3390/biology12060796 · Cited by 2
“The dysfunction of ASC has been associated with different types of cancer [9–12], diabetes [13], gout [14], and Alzheimer’s disease [15], among others [16–20].”
BackgroundKhachaturian, A. S., & Khachaturian, Z. S. (2023) · Care weekly · doi:10.14283/vme.2023.2 · Cited by 5
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.